Tbilisi Heart and Vascular Clinic, LTD

Tbilisi 48159

2 studies enrolling now · 15 studies all time

What they study most

Acute Myocardial Infarction, Amyloidosis, Angina Pectoris, Arthritis, Psoriatic, Atherosclerotic Cardiovascular Disease, Coronary Artery Disease, Diabetic Kidney Disease, Lupus Erythematosus, Systemic, Neuropsychiatric Symptoms Related to Neurodegenerative Disease, Recent Onset type1 Diabetes, Rheumatoid Arthritis, Type 2 Diabetes Mellitus

Studies at this site

• A Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial Disease — Running, not enrolling
• Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus — Enrolling by invitation
• A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus — Running, not enrolling
• Selatogrel Outcome Study in Suspected Acute Myocardial Infarction — Enrolling by invitation
• CRF2 Agonist for the Treatment of Worsening Heart Failure — Paused
• A Study of Guselkumab in Participants With Active Psoriatic Arthritis — Running, not enrolling
• A Study of Oral Ladarixin in Recent Onset Type 1 Diabetes and a Low Residual β-cell Function — Stopped early
• Phase 2 Study of INV-202 in Patients With Diabetic Kidney Disease — Completed
• A Safety Study of Pimavanserin in Adult and Elderly Subjects Experiencing Neuropsychiatric Symptoms Related to Neurodegenerative Disease — Completed
• Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease — Completed
• Cardiovascular Outcome Study to Evaluate the Effect of Obicetrapib in Patients With Cardiovascular Disease — Running, not enrolling
• A Study Of PF-06410293 (Adalimumab-Pfizer) And Adalimumab (Humira®) In Combination With Methotrexate In Subjects With Active Rheumatoid Arthritis (REFLECTIONS B538-02). — Completed
• A Study of PF-06438179 (Infliximab-Pfizer) and Infliximab in Combination With Methotrexate in Subjects With Active Rheumatoid Arthritis (REFLECTIONS B537-02). — Completed
• Efficacy and Safety Study of KIACTA in Preventing Renal Function Decline in AA Amyloidosis — Completed
• Type 2 Diabetes Evaluation of Ranolazine in Subjects With Chronic Stable Angina — Completed